switching from semiglutide to tirzepatide and Semaglutide key differences, weight loss results (2026) Switch from Tirzepatide to Semaglutide?
Description
The study by Ghusn and colleagues was a retrospective cohort analysis using electronic medical records that found a mean 6month body weight reduction of 10.9% among 102 patients who were treated with 1.7 or 2.4 mg of semaglutide at a specialty weight management clinic in a large health system
Exerc Immunol
Drug treatment can help achieve and sustain a low glycated hemoglobin (HbA1c) level
Seufert J, Lanzinger S, Danne T et al (2022) Real-world data of 12-month adjunct sodium-glucose co-transporter-2 inhibitor treatment in type 1 diabetes from the German/Austrian DPV registry: improved HbA1c without diabetic ketoacidosis
The metabolic reset from changing receptor stimulation patterns is part of the strategy
